Is the risk of brain metastasis and prognosis different in HER2-low breast cancer?

Saved in:
Bibliographic Details
Title: Is the risk of brain metastasis and prognosis different in HER2-low breast cancer?
Authors: Culha Y; Medical Oncology Clinic, Sivas Numune Hospital, Sivas, Turkey. drjasar@hotmail.com., Ünlü B; Department of Internal Medicine and Medical Oncology, Afyonkarahisar Health Sciences University School of Medicine, Afyonkarahisar, Turkey., Davarcı SE; Department of Internal Medicine and Medical Oncology, Afyonkarahisar Health Sciences University School of Medicine, Afyonkarahisar, Turkey., Güzel HG; Medical Oncology Clinic, Antalya Training and Research Hospital, Antalya, Turkey., Demir H; Department of Internal Medicine and Medical Oncology, Afyonkarahisar Health Sciences University School of Medicine, Afyonkarahisar, Turkey., Öztürk B; Medical Oncology Clinic, Antalya Training and Research Hospital, Antalya, Turkey., Baykara M; Department of Internal Medicine and Medical Oncology, Afyonkarahisar Health Sciences University School of Medicine, Afyonkarahisar, Turkey.
Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 May; Vol. 28 (5), pp. 1624-1636. Date of Electronic Publication: 2025 Nov 12.
Publication Type: Journal Article
Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1699-3055
DOI:10.1007/s12094-025-04106-6